Skip to main content

Lakeland to Use Rosetta Resolver for Clinical Cancer Research

NEW YORK, Feb. 6 (GenomeWeb News) - Lakeland Regional Cancer Center has licensed the Rosetta Resolver software system to investigate the clinical value of microarrays for assisting in cancer staging, the licensing partners said today.

The Florida-based center will use the technology for investigating the clinical value of oligonucleotide microarrays, according to a statement.

No further details were released.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.